Last updated: 14 May 2024 at 5:06pm EST

Richard Miller Net Worth




The estimated Net Worth of Richard A Md Miller is at least $3.74 Million dollars as of 6 May 2024. Mr. Miller owns over 577,634 units of Corvus Pharmaceuticals Inc stock worth over $2,639,787 and over the last 9 years he sold CRVS stock worth over $0. In addition, he makes $1,098,040 as Chairman of the Board, President, and Chief Executive Officer at Corvus Pharmaceuticals Inc.

Mr. Miller CRVS stock SEC Form 4 insiders trading

Richard has made over 23 trades of the Corvus Pharmaceuticals Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 577,634 units of CRVS stock worth $999,307 on 6 May 2024.

The largest trade he's ever made was buying 577,634 units of Corvus Pharmaceuticals Inc stock on 6 May 2024 worth over $999,307. On average, Richard trades about 31,688 units every 81 days since 2016. As of 6 May 2024 he still owns at least 577,634 units of Corvus Pharmaceuticals Inc stock.

You can see the complete history of Mr. Miller stock trades at the bottom of the page.





Richard Miller biography

Richard A. Miller M.D. serves as Chairman of the Board, President, Chief Executive Officer of the Company. Dr. Miller was Chairman and Chief Executive Officer of Graphea, Inc., a privately-held chemical company, which he founded. Dr. Miller served as Chief Commercialization Officer, Associate Dean and Research Professor in Chemistry at The University of Texas at Austin from September 2010 to December 2011. Dr. Miller founded Principia Biopharma Inc., a privately-held biopharmaceutical company, and served as its President and Chief Executive Officer and a member of its board of directors from January 2009 to February 2011. He served as President, Chief Executive Officer and Director of Pharmacyclics, Inc., a public biopharmaceutical company, from 1991, when he co-founded the company, to 2008. At Pharmacyclics, Dr. Miller led the initial discovery and development efforts for ibrutinib. Dr. Miller was a co-founder, Vice President and Director of IDEC Pharmaceuticals Corporation, a biotechnology company that merged with Biogen, Inc. in June 2003, where he led research efforts on lymphoma leading to the development of rituximab. Dr. Miller has been Adjunct Clinical Professor of Medicine (Oncology) at Stanford University Medical Center since 1991. Dr. Miller received a B.A. in Chemistry from Franklin & Marshall College and an M.D. from the State University of New York Medical School. He is board certified in both Internal Medicine and Medical Oncology.

What is the salary of Richard Miller?

As the Chairman of the Board, President, and Chief Executive Officer of Corvus Pharmaceuticals Inc, the total compensation of Richard Miller at Corvus Pharmaceuticals Inc is $1,098,040. There are 2 executives at Corvus Pharmaceuticals Inc getting paid more, with Daniel Hunt having the highest compensation of $1,554,080.



How old is Richard Miller?

Richard Miller is 69, he's been the Chairman of the Board, President, and Chief Executive Officer of Corvus Pharmaceuticals Inc since 2014. There are 1 older and 16 younger executives at Corvus Pharmaceuticals Inc. The oldest executive at Corvus Pharmaceuticals Inc is Dr. Richard A. Miller M.D., 70, who is the Co-Founder, Pres, CEO & Chairman.

What's Richard Miller's mailing address?

Richard's mailing address filed with the SEC is C/O CORVUS PHARMACEUTICALS, INC., 863 MITTEN ROAD, SUITE 102, BURLINGAME, CA, 94010.

Insiders trading at Corvus Pharmaceuticals Inc

Over the last 9 years, insiders at Corvus Pharmaceuticals Inc have traded over $52,808,904 worth of Corvus Pharmaceuticals Inc stock and bought 11,523,300 units worth $85,214,510 . The most active insiders traders include Holdings A/S Novo, Street Partners Llc Adams, and Capital, Llc Eco R1. On average, Corvus Pharmaceuticals Inc executives and independent directors trade stock every 46 days with the average trade being worth of $1,530,854. The most recent stock trade was executed by William Benton Jones on 6 May 2024, trading 20,000 units of CRVS stock currently worth $34,600.



What does Corvus Pharmaceuticals Inc do?

corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.



What does Corvus Pharmaceuticals Inc's logo look like?

Corvus Pharmaceuticals Inc logo

Complete history of Mr. Miller stock trades at Corvus Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
6 May 2024 Richard A Md Miller
President and CEO
Buy 577,634 $1.73 $999,307
6 May 2024
577,634
13 Dec 2022 Richard A Md Miller
President and CEO
Buy 60,000 $0.75 $45,000
13 Dec 2022
1,490,119
28 Sep 2022 Richard A Md Miller
President and CEO
Buy 25,000 $0.76 $19,000
28 Sep 2022
1,394,405
20 Sep 2022 Richard A Md Miller
President and CEO
Buy 20,000 $0.81 $16,200
20 Sep 2022
1,369,405
24 Jun 2022 Richard A Md Miller
President and CEO
Buy 10,000 $1.01 $10,100
24 Jun 2022
1,349,405
2 Jun 2022 Richard A Md Miller
President and CEO
Buy 5,890 $0.98 $5,772
2 Jun 2022
1,339,405
31 Mar 2022 Richard A Md Miller
President and CEO
Buy 15,000 $1.64 $24,600
31 Mar 2022
1,333,515
15 Mar 2022 Richard A Md Miller
President and CEO
Buy 30,000 $1.49 $44,700
15 Mar 2022
1,318,515
20 Aug 2021 Richard A Md Miller
President and CEO
Buy 10,000 $1.93 $19,300
20 Aug 2021
1,288,515
4 May 2021 Richard A Md Miller
President and CEO
Buy 35,714 $2.80 $99,999
4 May 2021
35,714
17 Feb 2021 Richard A Md Miller
President and CEO
Buy 100,000 $3.50 $350,000
17 Feb 2021
1,278,515
12 Nov 2019 Richard A Md Miller
President and CEO
Buy 15,008 $3.00 $45,024
12 Nov 2019
1,178,515
6 Aug 2019 Richard A Md Miller
President and CEO
Buy 7,500 $3.56 $26,700
6 Aug 2019
1,163,507
13 Jun 2019 Richard A Md Miller
President and CEO
Buy 12,000 $3.41 $40,920
13 Jun 2019
1,156,007
7 Jun 2019 Richard A Md Miller
President and CEO
Buy 15,212 $3.49 $53,090
7 Jun 2019
1,144,007
27 Dec 2018 Richard A Md Miller
President and CEO
Buy 20,000 $3.29 $65,800
27 Dec 2018
1,128,795
20 Dec 2018 Richard A Md Miller
President and CEO
Buy 10,000 $4.40 $44,000
20 Dec 2018
1,108,795
6 Dec 2018 Richard A Md Miller
President and CEO
Buy 5,000 $5.99 $29,950
6 Dec 2018
1,118,795
4 Dec 2018 Richard A Md Miller
President and CEO
Buy 1,502 $5.95 $8,937
4 Dec 2018
1,113,795
12 Mar 2018 Richard A Md Miller
President and CEO
Buy 100,000 $8.50 $850,000
12 Mar 2018
1,112,293
20 Nov 2017 Richard A Md Miller
President and CEO
Buy 10,000 $10.79 $107,900
20 Nov 2017
1,012,293
9 Jun 2017 Richard A Md Miller
President and CEO
Buy 25,000 $9.88 $247,000
9 Jun 2017
1,002,293
12 May 2016 Richard A Md Miller
President and CEO
Buy 30,300 $10.00 $303,000
12 May 2016
1,077,293


Corvus Pharmaceuticals Inc executives and stock owners

Corvus Pharmaceuticals Inc executives and other stock owners filed with the SEC include: